Home » Topics » BioWorld Science

BioWorld Science
RSS

C4X licenses orexin-1 receptor antagonist C4X-3256 to Indivior

March 29, 2018

Redx suspends enrollment in phase I/IIa study of RXC-004

March 29, 2018

Zeria Pharmaceutical applies for approval of Z-213 in Japan

March 29, 2018

Takeda considers making offer for Shire

March 29, 2018

Janssen files for approval of apalutamide in Japan

March 29, 2018

Prometic Life Sciences offers new data from phase II study of PBI-4050 in Alstrom syndrome

March 29, 2018

METTL3 linked to hepatocellular carcinogenesis

March 29, 2018

Five Prime initiates phase I study of first-in-class B7-H4 antibody FPA-150

March 29, 2018

Kazia Therapeutics initiates phase II trial of GDC-0084

March 29, 2018

pSivida announces acquisition of Icon Bioscience

March 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...